European Society of Cardiology Congress
A slow heart rhythm puts patients at risk of early death, but a cardiac implant may help reset those odds, according to a Dutch study presented this week at the European Society of Cardiology Congress in Amsterdam.
A study of pacemakers in 23 Dutch hospitals found that devices implanted to treat slow heart rhythm helped restore normal life expectancy.
Physicians and medical boards may have to reconsider decades of cardiogenic shock treatment after the highly anticipated IABP-Shock study found no significant benefit in using intra-aortic balloon pump therapy in heart attack patients.
German doctors have adopted transcatheter aortic valve implantation faster than any other country, according to researchers attending the European Society of Cardiology Congress in Munich.
Analyses of the country’s German Aortic Valve Registry suggest that, although about half of all elderly patients are receiving TAVI therapy, doctors are primarily recommending the procedure for high-risk patients, as advised.
This year’s European Society of Cardiology Congress in Munich, Germany, hosted a fleet of new studies and technologies, but renal denervation hogged the spotlight with no less than 5 research teams presenting evidence of the healing powers of the nerve-deadening procedure.
Teams from Germany, the Czech Republic, France and Australia presented positive findings for renal denervation in treating hypertension better than drugs, improving physical and mental health and reducing stiffness in arteries.
St. Jude Medical Inc.’s (NYSE:STJ) Riata family of leads have come under fire again for "insulation breaches" at rates much higher than first reported by the company in a 2010 warning letter.
In a small Irish study of 212 patients with Riata defibrillator leads, 15 percent had confirmed cases of lead wires poking through the silicone rubber insulating cables and making contact with tissue at an average of about 4 years after implantation.